Journal of Hematology

Editor-in-Chief
Roberto Castelli, MD, PhD, Professor, Division of Internal Medicine, Department of Biomedical and Clinical Sciences, University of Milan, Italy

ISSN 1927-1212 print
ISSN 1927-1220 online
Frequency: Quarterly
Journal Access: Open Access
Indexed and covered by: Chemical Abstract (CA);
Worldcat; Google; Google Scholar; JournalTOCs; PubMed Central; PubMed; Web of Science (Emerging Sources Citation Index-ESCI).
Journal archiving and digital preservation: Portico

 

Combat the COVID-19

Let's Combat COVID-19 Pandemic Together
The COVID-19 outbreak presents the unprecedented challenge for world public and medical practitioners and health care providers. The Elmer Press Inc is herein to participate the combating COVID-19 through all possible efforts, as a clinical medicine publisher, we would facilitate the rapid and effective communication of management of this pandemic, we will consider submissions related to all aspects of this disease, including prevention, basic viral research, epidemiology, treatment, vaccine, fast screening, diagnosis, prognosis, etc. We will process such manuscripts in priority and publish them ASAP after peer-reviewed and accepted.


Highlights

  • Ofatumumab and Complement Replacement in Relapsed/Refractory Chronic Lymphocytic Leukemia

    We conducted a phase 2 trial involving patients with relapsed/refractory chronic lymphocytic leukemia (CLL). Patients were treated with ofatumumab with fresh frozen plasma (FFP) used as a source of complement replacement.

    Read More >>
  • Spontaneous Remission in a Patient With Acute Myeloid Leukemia Leading to Undetectable Minimal Residual Disease

    Although rare, spontaneous remission (SR) of acute myeloid leukemia (AML) has been reported in the literature, the underlying mechanisms driving remission remain unknown. However, it is most commonly associated with a preceding severe infection.

    Read More >>
  • Impact of Opioid Use in Hematological Malignancies: Clinical, Immunological and Concomitant Aspects

    Opioid agents play a unique role in pain and symptom management for cancer patients. Research shows that opiate use, especially when associated with underlying cancer, has significant effects on hematological parameters.

    Read More >>
  • Outcomes of Reduced Frequency Dosing of Ibrutinib in Chronic Lymphocytic Leukemia Patients Following Complete or Partial Remission: A Pilot Study

    Ibrutinib is a Bruton’s tyrosine kinase inhibitor that has shown to be a superior choice in the treatment of chronic lymphocytic leukemia (CLL) and a simple, oral alternative to other chemoimmunotherapies.

    Read More >>
  • Delayed Thrombotic Complications in a Thrombotic Thrombocytopenic Purpura Patient Treated With Caplacizumab

    Caplacizumab has emerged as a promising new drug for the management of TTP. We report the case of a patient with idiopathic refractory TTP treated with caplacizumab who developed thrombotic complications upon discontinuation of treatment.

    Read More >>

Viewpoints

 

 

Featured

 

Abnormal Hemostatic Parameters and Risk of Thromboembolism Among Patients With COVID-19 Infection
COVID-19 produces a sort of DIC which is usually characterized by hypercoagulability. The exact pathogenetic mechanism of COVID-19-related DIC is unclear, although inflammatory drive and cytokine release may be responsible for the observed coagulation impairment leading to thromboembolic complications. Read the Full Text

Management of Iron-Deficiency Anemia on Inpatients and Appropriate Discharge and Follow-Up
The aims of the study were to identify appropriate supplementation of iron for inpatients and to identify factors involved in appropriate discharge documentation and follow-up. This was a retrospective analysis of 103 patients at a community hospital in New York City. Read the Full Text


Image of the Issue

Novel Translocation in Acute Myeloid Leukemia: Case Report and Review of Risk-Stratification and Induction Chemotherapy in Patients With Acute Myeloid Leukemia
Identification of chromosomal abnormalities in patients with acute myeloid leukemia (AML) has contributed substantially to our current understanding of the molecular pathogenesis underlying leukemogenesis, and risk-stratification based on molecular abnormalities both influences treatment strategies and aids in determining prognosis. Full Text


Current Issue

Past Issues

Vol. 9, No. 3, Sept 2020

Table of Contents

Review

Impact of Opioid Use in Hematological Malignancies: Clinical, Immunological and Concomitant Aspects Abstract HTML PDF
Polina Tregubenko, Valeriy Zvonarev 41-54
doi: https://doi.org/10.14740/jh689

Original Article

Outcomes of Reduced Frequency Dosing of Ibrutinib in Chronic Lymphocytic Leukemia Patients Following Complete or Partial Remission: A Pilot Study Abstract HTML PDF
William Alexander, Sarah Davis, Raj Ramakrishna, Arumugam Manoharan 55-61
doi: https://doi.org/10.14740/jh676
Clinical Impact of Percentage of Natural Killer Cells and Natural Killer-Like T Cell Population in Acute Myeloid Leukemia Abstract HTML PDF
Esraa Jamal, Emad Azmy, Mohamed Ayed, Salah Aref, Noha Eisa 62-70
doi: https://doi.org/10.14740/jh655

Short Communication

Clinical Features of Plasmablastic Lymphoma: Case Series From an Asian Tertiary Cancer Center and Literature Review Abstract HTML PDF Suppl1
Daniel Ren Yi Yap, Grace Fangmin Tan, Esther Wei Yin Chang, Valerie Shiwen Yang, Eileen Yi Ling Poon, Nagavalli Somasundaram, Mohamad Farid, Tiffany Tang, Miriam Tao, Soon Thye Lim, Jason Yongsheng Chan 71-78
doi: https://doi.org/10.14740/jh672
Ofatumumab and Complement Replacement in Relapsed/Refractory Chronic Lymphocytic Leukemia Abstract HTML PDF Suppl1
Joseph Tuscano, Christina Poh, Aaron Rosenberg, Brian Jonas, Mehrdad Abedi, Gustavo Barisone, Emily Schwab, Kathleen Lundeberg, Paul Kaesberg 79-83
doi: https://doi.org/10.14740/jh721

Case Report

Delayed Thrombotic Complications in a Thrombotic Thrombocytopenic Purpura Patient Treated With Caplacizumab Abstract HTML PDF
Nicolas Cilla, Julie Dallemagne, Marie Vanhove, Patrick Stordeur, Serge Motte, Virginie De Wilde 84-88
doi: https://doi.org/10.14740/jh614
Severe Peripheral Neuropathy From Treatment With Arsenic Trioxide in a Patient Suffering From Acute Promyelocytic Leukemia Abstract HTML PDF
Soren Niemi Helso, Anne Stidsholt Roug, Morten Mork, Eva Futtrup Maksten, Marianne Tang Severinsen 89-92
doi: https://doi.org/10.14740/jh617

Letter to the Editor

Prevalence of Sickle Cell Trait and Rare Hemoglobin Variants in the Metropolitan Washington DC Area Abstract HTML PDF Suppl1 Suppl2
Xiaomei Niu, Christian S. Parry, Angela Mason, Barbara Harrison, Seyed Mehdi Nouraie, Tatiana Ammosova, Juan Salomon-Andonie, Patricia A. Oneal, Victor R. Gordeuk, James G. Taylor, Sergei Nekhai 93-95
doi: https://doi.org/10.14740/jh603
 

Browse  Journals  

     

Journal of clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

Journal of Neurology Research

International Journal of Clinical Pediatrics

 

 

 

 

 

Journal of Hematology, quarterly, ISSN 1927-1212 (print), 1927-1220 (online), published by Elmer Press Inc.                   
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC BY-NC 4.0)



This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.thejh.org    editorial contact: editor@thejh.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada
 

© Elmer Press Inc. All Rights Reserved.